Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
|
CN |
|
Kawata Mfg. Co Ltd
TSE:6292
|
JP |
|
Laxmi Cotspin Ltd
NSE:LAXMICOT
|
IN |
|
A
|
Anhui Transport Consulting & Design Institute Co Ltd
SSE:603357
|
CN |
|
Cheniere Energy Partners LP
NYSE:CQP
|
US |
|
Incentiapay Ltd
ASX:INP
|
AU |
|
Jubilant Ingrevia Ltd
NSE:JUBLINGREA
|
IN |
|
Atrae Inc
TSE:6194
|
JP |
|
K
|
Kuala Lumpur Kepong Bhd
KLSE:KLK
|
MY |
|
N
|
Northbaze Group AB
STO:NBZ
|
SE |
Zhejiang Starry Pharmaceutical Co Ltd
Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series. The company is headquartered in Taizhou, Zhejiang and currently employs 1,818 full-time employees. The company went IPO on 2016-03-09. The X-ray contrast medium's major product is iohexol active pharmaceutical ingredient. Quinolone antimicrobial agents' major products are levofloxacin hydrochloride active pharmaceutical ingredient and levofloxacin hemihydrates active pharmaceutical ingredient.
Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series. The company is headquartered in Taizhou, Zhejiang and currently employs 1,818 full-time employees. The company went IPO on 2016-03-09. The X-ray contrast medium's major product is iohexol active pharmaceutical ingredient. Quinolone antimicrobial agents' major products are levofloxacin hydrochloride active pharmaceutical ingredient and levofloxacin hemihydrates active pharmaceutical ingredient.
